Best of SABCS® - Central

Regional Director
Kathy S. Albain, MD, FACP, FASCO
Program Goals & Content Overview
As new clinical data continues to emerge as a result of ongoing research in breast cancer diagnostics and therapeutics, official Best of SABCS® programs cover these important developments in each of the live, regional events. Each regional event provides an educational forum for local researchers and clinicians to discuss the most pertinent basic, translational, and clinical breast cancer research presented at the annual SABCS® meeting.
Topics and discussions for each Best of SABCS® program are drawn from key presentations at SABCS® 2023, focusing on results of breast cancer research that helps clinicians understand current trends and forthcoming treatments that will optimize patient care outcomes. Significantly important content from SABCS® includes new drug therapy approvals and clinical trial results, updates in breast cancer screening and diagnostics, and best practices to be implemented in clinical care of patients.
The goals of the Best of SABCS® programs are to review and critically assess practice-changing results of emerging breast cancer research, propose best practices for implementing diagnostic and therapeutic strategies, and close knowledge and clinical practice gaps in the management of patients with breast cancer.
Date & Time
February 3 2024 8:00 am - 1:30 pm
Loews Chicago Hotel 455 North Park Drive,Chicago, IL 60611
Program Fee
Nurse/Nurse Practitioner/Physician Assistant
Past Best of SABCS Central program attendee
2023 Preliminary Agenda
7:00 - 8:00 AM
Registration, Continental Breakfast and visit with Exhibitors

8:00 - 8:10 AM
Welcome and Introductions

Kathy S. Albain, MD, FACP, FASCO Huizenga Family Endowed Chair in Oncology Research Professor of Medicine, Division of Hematology/Oncology Loyola University Chicago Stritch School of Medicine Cardinal Bernardin Cancer Center, Loyola University Medical Center

Introduction of Program and Faculty Pre-Test Questions

8:10 - 8:35 AM
Immunotherapy for ER-negative and ER-positive Breast Cancer

Erin Frances Cobain, MD Assistant Professor, Medical Oncology, Internal Medicine Rogel Cancer Center, University of Michigan

8:35 - 8:45 AM

Questions and Answers session with Dr. Cobain

8:50 - 9:15 AM
High Impact Translational and Basic Science Research

Suzanne A. W. Fuqua, PhD Professor of Medicine and Co-Leader, Nuclear Receptor Program, Baylor College of Medicine

9:15 - 9:25 AM

Questions and Answers session with Dr. Fuqua

9:30 - 9:55 AM
Targeted Therapies (non-immunotherapy) for ER-positive early stage disease

Kevin Kalinsky, MD, MS Louisa and Rand Glenn Family Chair in Breast Cancer Research Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine Director, Glenn Family Breast Center at the Winship Cancer Institute

10:00 - 10:25 AM
New Treatment approaches (non-immunotherapy) for ER-positive metastatic disease

Cynthia X. Ma, MD, PhD Professor, John T. Milliken Department of Medicine, Division of Clinical Oncology, Washington University School of Medicine-St. Louis

10:25 -10:40 AM

Questions and Answers session with Kalinsky and Ma - Moderated by Dr. Albain

10:40 -11:00 AM

Refreshment Break and Visit with Exhibitors

11:00 -11:25 AM
New Insights in Prevention, Health Care Delivery and Survivorship

Ann Partridge, MD, MPH Professor of Medicine, Harvard Medical School, Vice-Chair Medical Oncology, Dana-Farber Cancer Institute

11:30 -11:55 AM
Practice informing new results in Local-regional disease

Alastair Thompson, BSc (Hons), MBChB, MD, FRCS Professor and Chief, Section of Breast Surgery Baylor College of Medicine

12:00 - 12:25 PM
Advances and future directions in HER2-positive breast cancer

Ian Krop, MD, PhDProfessor of Internal Medicine (Medical Oncology), Associate Cancer Center Director, Director, Clinical Trials Office, Yale Cancer Center, Yale School of Medicine

12:25 -12:45 PM

Questions and Answers session with Drs. Partridge, Thompson and Krop Moderated by Dr. Albain

12:45 -1:00 PM

Post-Test Questions and Wrap Up Kathy S. Albain, MD, FACP, FASCO

1:00 PM

Best of SABCS-Central and 20th Annual Bench to Bedside Adjourns

1:00 -1:15 PM


1:15 -1:45 PM

Supported Symposium- Expanded Horizons: A Treatment for HR+/HER2- mBC and mTNBC Ami Shah, MD Assistant Professor of Medicine, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Accreditation Statement

The UT Health Science Center San Antonio is accredited by the ACCME (Accreditation Council for Continuing Medical Education) to provide continuing medical education for physicians.

The UT Health Science Center San Antonio has approved this program for AMA PRA Category 1 Credits™.

Target Audience
These regional Best of SABCS programs are directed to academic and community physicians, medical residents and fellows training in oncology subspecialties, physician assistants, nurse practitioners and basic/translational researchers involved in breast cancer. Specialties include medical, surgical, gynecologic, and radiation oncology, as well as other pertinent healthcare professionals involved in breast cancer medicine.
These programs are supported by educational grants from
Astra Zeneca
Daiichi Sankyo
Puma Biotechnology